ta-nic
Vaccineexperimental
Clinical trial activity
1 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2007 (NCT00633321)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- nicotineImmunity, active
nicotine immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ta-nic
- ta-nic
- ta-nic
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00633321 | Phase 2 | May 1, 2007 | Benchmark Research, Celtic Pharma Development Services, Centennial Medical Group, CNS Research, Inc., Columbia University, CRI Worldwide, Mayo Clinic |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Benchmark Research | For profit | 1 | 0 | 1 | 2007 |
| Celtic Pharma Development Services | For profit | 1 | 1 | 1 | 2007 |
| Centennial Medical Group | Academic/Hospital | 1 | 0 | 1 | 2007 |
| CNS Research, Inc. | For profit | 1 | 0 | 1 | 2007 |
| Columbia University | Academic/Hospital | 1 | 0 | 1 | 2007 |
| CRI Worldwide | For profit | 1 | 0 | 1 | 2007 |
| Mayo Clinic | Academic/Hospital | 1 | 0 | 1 | 2007 |
7 organizations
Page 1 / 1